LD-2 disclosure · 3rd Quarter - Report
ONYX PHARMACEUTICALS
Client
- Location
- District of Columbia · United States of America
Registrant
- Description
- Onyx Pharmaceuticals develops and commercialize innovative cancer therapies.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
3 issuesCopyright/Patent/Trademark
ACA and Patient Access ACA and Health Disparities Sequestration and its impact on NIH, FDA, and CDC budgets 340B program and orphan drug exclusionHealth disparities Onyx response to the June 4 announcement regarding the White House Task Force on High-Tech Patent Issues, Legislative Priorities and Executive Actions.
LobbyistsDEANNA DARLINGTON · mr JOHN EVERETT CROSLAND iii
Health Issues
ACA and Patient Access ACA and Health Disparities Sequestration and its impact on NIH, FDA, and CDC budgets 340B program and orphan drug exclusionHealth disparities Onyx response to the June 4 announcement regarding the White House Task Force on High-Tech Patent Issues, Legislative Priorities and Executive Actions.
LobbyistsDEANNA DARLINGTON · mr JOHN EVERETT CROSLAND iii
Medical/Disease Research/Clinical Labs
ACA and Patient Access ACA and Health Disparities Sequestration and its impact on NIH, FDA, and CDC budgets 340B program and orphan drug exclusionHealth disparities Onyx response to the June 4 announcement regarding the White House Task Force on High-Tech Patent Issues, Legislative Priorities and Executive Actions.
LobbyistsDEANNA DARLINGTON · mr JOHN EVERETT CROSLAND iii